CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 98 of 865
Non-Antibody Products
Page 98 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Betulinic Acid propargyl ester | An alkyne derivative of betulinic acid; has been used in click chemistry r… | 25 mg | 33030-25 | More Info |
| Betulinic Acid propargyl ester | An alkyne derivative of betulinic acid; has been used in click chemistry r… | 5 mg | 33030-5 | More Info |
| Betulinic Aldehyde | A triterpenoid with diverse biological activities; active against P. falci… | 1 mg | 27810-1 | More Info |
| Betulinic Aldehyde | A triterpenoid with diverse biological activities; active against P. falci… | 10 mg | 27810-10 | More Info |
| Betulinic Aldehyde | A triterpenoid with diverse biological activities; active against P. falci… | 25 mg | 27810-25 | More Info |
| Betulinic Aldehyde | A triterpenoid with diverse biological activities; active against P. falci… | 5 mg | 27810-5 | More Info |
| Betulinic Aldehyde oxime | A derivative of betulin; active against E. aerogenes, E. coli, E. faecalis… | 10 mg | 33027-10 | More Info |
| Betulinic Aldehyde oxime | A derivative of betulin; active against E. aerogenes, E. coli, E. faecalis… | 100 mg | 33027-100 | More Info |
| Betulinic Aldehyde oxime | A derivative of betulin; active against E. aerogenes, E. coli, E. faecalis… | 50 mg | 33027-50 | More Info |
| Betulinic glycine amide | A derivative of betulinic acid; has been used as a precursor in the synthe… | 1 mg | 33031-1 | More Info |
| Betulinic glycine amide | A derivative of betulinic acid; has been used as a precursor in the synthe… | 10 mg | 33031-10 | More Info |
| Betulinic glycine amide | A derivative of betulinic acid; has been used as a precursor in the synthe… | 25 mg | 33031-25 | More Info |
| Betulinic glycine amide | A derivative of betulinic acid; has been used as a precursor in the synthe… | 5 mg | 33031-5 | More Info |
| Betulonaldehyde | A pentacyclic triterpenoid; active against P. falciparum (IC50 = 3.36 &mic… | 10 mg | 33042-10 | More Info |
| Betulonaldehyde | A pentacyclic triterpenoid; active against P. falciparum (IC50 = 3.36 &mic… | 100 mg | 33042-100 | More Info |
| Betulonaldehyde | A pentacyclic triterpenoid; active against P. falciparum (IC50 = 3.36 &mic… | 50 mg | 33042-50 | More Info |
| Betulonic Acid | A triterpenoid; active against P. falciparum W2 clone (IC50 = 10.01 µ… | 10 mg | 29765-10 | More Info |
| Betulonic Acid | A triterpenoid; active against P. falciparum W2 clone (IC50 = 10.01 µ… | 25 mg | 29765-25 | More Info |
| Betulonic Acid | A triterpenoid; active against P. falciparum W2 clone (IC50 = 10.01 µ… | 5 mg | 29765-5 | More Info |
| Betulonic Acid | A triterpenoid; active against P. falciparum W2 clone (IC50 = 10.01 µ… | 50 mg | 29765-50 | More Info |
| Betulonic Acid methyl ester | A methyl ester form of betulonic acid | 1 mg | 33054-1 | More Info |
| Betulonic Acid methyl ester | A methyl ester form of betulonic acid | 10 mg | 33054-10 | More Info |
| Betulonic Acid methyl ester | A methyl ester form of betulonic acid | 25 mg | 33054-25 | More Info |
| Betulonic Acid methyl ester | A methyl ester form of betulonic acid | 5 mg | 33054-5 | More Info |
| Bevantolol (hydrochloride) | A β1-AR antagonist (Ki = 14.79 nM in rat cortical membranes); selecti… | 100 mg | 29792-100 | More Info |
| Bevantolol (hydrochloride) | A β1-AR antagonist (Ki = 14.79 nM in rat cortical membranes); selecti… | 250 mg | 29792-250 | More Info |
| Bevantolol (hydrochloride) | A β1-AR antagonist (Ki = 14.79 nM in rat cortical membranes); selecti… | 500 mg | 29792-500 | More Info |
| Bexarotene | An RXR agonist (EC50s = 28, 25, and 20 nM for RXRα, RXRβ, and R… | 10 mg | 11571-10 | More Info |
| Bexarotene | An RXR agonist (EC50s = 28, 25, and 20 nM for RXRα, RXRβ, and R… | 100 mg | 11571-100 | More Info |
| Bexarotene | An RXR agonist (EC50s = 28, 25, and 20 nM for RXRα, RXRβ, and R… | 25 mg | 11571-25 | More Info |
| Bexarotene | An RXR agonist (EC50s = 28, 25, and 20 nM for RXRα, RXRβ, and R… | 50 mg | 11571-50 | More Info |
| Bexarotene-d4 | An internal standard for the quantification of bexarotene by GC- or LC-MS | 1 mg | 22610-1 | More Info |
| Bezafibrate | A non-selective PPAR agonist (EC50s = 50, 60, and 20 µM for human PP… | 1000 mg | 10009145-1 | More Info |
| Bezafibrate | A non-selective PPAR agonist (EC50s = 50, 60, and 20 µM for human PP… | 10000 mg | 10009145-10 | More Info |
| Bezafibrate | A non-selective PPAR agonist (EC50s = 50, 60, and 20 µM for human PP… | 500 mg | 10009145-500 | More Info |
| Bezafibrate | A non-selective PPAR agonist (EC50s = 50, 60, and 20 µM for human PP… | 5000 mg | 10009145-5 | More Info |
| Bezafibrate-d4 | An internal standard for the quantification of bezafibrate by GC- or LC-MS | 1 mg | 28526-1 | More Info |
| BFH772 | An inhibitor of VEGFR2 (IC50 = 0.0027 µM for the human receptor); se… | 1 mg | 21386-1 | More Info |
| BFH772 | An inhibitor of VEGFR2 (IC50 = 0.0027 µM for the human receptor); se… | 10 mg | 21386-10 | More Info |
| BFH772 | An inhibitor of VEGFR2 (IC50 = 0.0027 µM for the human receptor); se… | 25 mg | 21386-25 | More Info |
| BFH772 | An inhibitor of VEGFR2 (IC50 = 0.0027 µM for the human receptor); se… | 5 mg | 21386-5 | More Info |
| BG45 | A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combinatio… | 10 mg | 16918-10 | More Info |
| BG45 | A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combinatio… | 25 mg | 16918-25 | More Info |
| BG45 | A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combinatio… | 5 mg | 16918-5 | More Info |
| BG45 | A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combinatio… | 50 mg | 16918-50 | More Info |
| BGC 20-1531 (hydrochloride) | A potent and selective EP4 receptor antagonist (Kis = 11.7, >10,000, and >… | 1 mg | 19742-1 | More Info |
| BGC 20-1531 (hydrochloride) | A potent and selective EP4 receptor antagonist (Kis = 11.7, >10,000, and >… | 10 mg | 19742-10 | More Info |
| BGC 20-1531 (hydrochloride) | A potent and selective EP4 receptor antagonist (Kis = 11.7, >10,000, and >… | 5 mg | 19742-5 | More Info |
| BGC 20-1531 (hydrochloride) | A potent and selective EP4 receptor antagonist (Kis = 11.7, >10,000, and >… | 500 µg | 19742-500 | More Info |
| BGJ398 | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 1 mg | 19157-1 | More Info |
| BGJ398 | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 10 mg | 19157-10 | More Info |
| BGJ398 | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 25 mg | 19157-25 | More Info |
| BGJ398 | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 5 mg | 19157-5 | More Info |
| BGJ398 (phosphate) | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 1 mg | 39292-1 | More Info |
| BGJ398 (phosphate) | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 10 mg | 39292-10 | More Info |
| BGJ398 (phosphate) | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 25 mg | 39292-25 | More Info |
| BGJ398 (phosphate) | A pan FGFR inhibitor (IC50s = 0.9, 1.4, and 1 nM for FGFR1, FGFR2, and FGF… | 5 mg | 39292-5 | More Info |
| BGP-15 | A PARP inhibitor and insulin sensitizer; blocks self-ADP-ribosylation of n… | 1 mg | 17503-1 | More Info |
| BGP-15 | A PARP inhibitor and insulin sensitizer; blocks self-ADP-ribosylation of n… | 10 mg | 17503-10 | More Info |
| BGP-15 | A PARP inhibitor and insulin sensitizer; blocks self-ADP-ribosylation of n… | 25 mg | 17503-25 | More Info |
| BGP-15 | A PARP inhibitor and insulin sensitizer; blocks self-ADP-ribosylation of n… | 5 mg | 17503-5 | More Info |
| BHBM | An acylhydrazone with antifungal activity; active against C. neoformans in… | 1 mg | 29817-1 | More Info |
| BHBM | An acylhydrazone with antifungal activity; active against C. neoformans in… | 10 mg | 29817-10 | More Info |
| BHBM | An acylhydrazone with antifungal activity; active against C. neoformans in… | 25 mg | 29817-25 | More Info |
| BHBM | An acylhydrazone with antifungal activity; active against C. neoformans in… | 5 mg | 29817-5 | More Info |
| B7-H3/CD276 Extracellular Domain (human, recombinant) | Source: Recombinant C-terminal human IgG1 Fc-tagged B7-H3 expressed in HEK… | 1 mg | 31822-1 | More Info |
| B7-H3/CD276 Extracellular Domain (human, recombinant) | Source: Recombinant C-terminal human IgG1 Fc-tagged B7-H3 expressed in HEK… | 100 µg | 31822-100 | More Info |
| BHD | A reversible male contraceptive agent; induces spermatogenic cell apoptosi… | 1 mg | 38962-1 | More Info |
| BHD | A reversible male contraceptive agent; induces spermatogenic cell apoptosi… | 10 mg | 38962-10 | More Info |
| BHD | A reversible male contraceptive agent; induces spermatogenic cell apoptosi… | 5 mg | 38962-5 | More Info |
| B7-H4 (human, recombinant) | Source: Active recombinant C-terminal human IgG1 Fc-tagged B7-H4 expressed… | 1 mg | 31823-1 | More Info |
| B7-H4 (human, recombinant) | Source: Active recombinant C-terminal human IgG1 Fc-tagged B7-H4 expressed… | 100 µg | 31823-100 | More Info |
| BH3I-1 | A cell permeable inhibitor that blocks the binding of BH3 peptides to Bcl-… | 1 mg | 18763-1 | More Info |
| BH3I-1 | A cell permeable inhibitor that blocks the binding of BH3 peptides to Bcl-… | 10 mg | 18763-10 | More Info |
| BH3I-1 | A cell permeable inhibitor that blocks the binding of BH3 peptides to Bcl-… | 25 mg | 18763-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile